188 related articles for article (PubMed ID: 36768994)
21. Expression profiling of signal transducer and activator of transcription3 in oral squamous cell carcinoma in south Indian population.
Thomas P; Selvakumar SC; Preethi KA; Sekar D
Minerva Dent Oral Sci; 2024 Feb; 73(1):37-44. PubMed ID: 37878241
[TBL] [Abstract][Full Text] [Related]
22. HMG20A was identified as a key enhancer driver associated with DNA damage repair in oral squamous cell carcinomas.
Na L; Meijie Z; Wenjing Z; Bing Z; Yanhao D; Shanshan L; Yongle Q
BMC Oral Health; 2022 Nov; 22(1):473. PubMed ID: 36335317
[TBL] [Abstract][Full Text] [Related]
23. Migration and invasion of oral squamous carcinoma cells is promoted by WNT5A, a regulator of cancer progression.
Prgomet Z; Axelsson L; Lindberg P; Andersson T
J Oral Pathol Med; 2015 Nov; 44(10):776-84. PubMed ID: 25459554
[TBL] [Abstract][Full Text] [Related]
24. [MicroRNA model that can predict the prognosis of oral squamous cell carcinoma based on bioinformatics analysis].
Zhao G; Li CX; Guo C; Zhu H
Hua Xi Kou Qiang Yi Xue Za Zhi; 2020 Dec; 38(6):622-627. PubMed ID: 33377337
[TBL] [Abstract][Full Text] [Related]
25. Epigenomic dysregulation-mediated alterations of key biological pathways and tumor immune evasion are hallmarks of gingivo-buccal oral cancer.
Das D; Ghosh S; Maitra A; Biswas NK; Panda CK; Roy B; Sarin R; Majumder PP
Clin Epigenetics; 2019 Dec; 11(1):178. PubMed ID: 31796082
[TBL] [Abstract][Full Text] [Related]
26. Screening and identification of autophagy-related biomarkers for oral squamous cell carcinoma (OSCC) via integrated bioinformatics analysis.
Huang GZ; Lu ZY; Rao Y; Gao H; Lv XZ
J Cell Mol Med; 2021 May; 25(9):4444-4454. PubMed ID: 33837652
[TBL] [Abstract][Full Text] [Related]
27. Carboxylesterase 2 induces mitochondrial dysfunction via disrupting lipid homeostasis in oral squamous cell carcinoma.
Chen X; Liu Q; Chen Y; Wang L; Yang R; Zhang W; Pan X; Zhang S; Chen C; Wu T; Xia J; Cheng B; Chen X; Ren X
Mol Metab; 2022 Nov; 65():101600. PubMed ID: 36113774
[TBL] [Abstract][Full Text] [Related]
28. Decreased CSTA expression promotes lymphatic metastasis and predicts poor survival in oral squamous cell carcinoma.
Wang Y; Wang L; Li X; Qu X; Han N; Ruan M; Zhang C
Arch Oral Biol; 2021 Jun; 126():105116. PubMed ID: 33831734
[TBL] [Abstract][Full Text] [Related]
29. Notch Signaling Activation Is Associated with Patient Mortality and Increased FGF1-Mediated Invasion in Squamous Cell Carcinoma of the Oral Cavity.
Weaver AN; Burch MB; Cooper TS; Della Manna DL; Wei S; Ojesina AI; Rosenthal EL; Yang ES
Mol Cancer Res; 2016 Sep; 14(9):883-91. PubMed ID: 27353029
[TBL] [Abstract][Full Text] [Related]
30. In vitro and in silico validation of CA3 and FHL1 downregulation in oral cancer.
Pereira CM; de Carvalho AC; da Silva FR; Melendez ME; Lessa RC; Andrade VCC; Kowalski LP; Vettore AL; Carvalho AL
BMC Cancer; 2018 Feb; 18(1):193. PubMed ID: 29454310
[TBL] [Abstract][Full Text] [Related]
31. Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma.
Lv Z; Wu X; Cao W; Shen Z; Wang L; Xie F; Zhang J; Ji T; Yan M; Chen W
J Exp Clin Cancer Res; 2014 Dec; 33(1):100. PubMed ID: 25539663
[TBL] [Abstract][Full Text] [Related]
32. A γ-Secretase Inhibitor Attenuates Cell Cycle Progression and Invasion in Human Oral Squamous Cell Carcinoma: An In Vitro Study.
Pongjantarasatian S; Nowwarote N; Rotchanakitamnuai V; Srirodjanakul W; Saehun R; Janebodin K; Manokawinchoke J; Fournier BPJ; Osathanon T
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012128
[TBL] [Abstract][Full Text] [Related]
33. Translational genomics and recent advances in oral squamous cell carcinoma.
Chai AWY; Lim KP; Cheong SC
Semin Cancer Biol; 2020 Apr; 61():71-83. PubMed ID: 31542510
[TBL] [Abstract][Full Text] [Related]
34. Genome-wide CRISPR screens of oral squamous cell carcinoma reveal fitness genes in the Hippo pathway.
Chai AWY; Yee PS; Price S; Yee SM; Lee HM; Tiong VK; Gonçalves E; Behan FM; Bateson J; Gilbert J; Tan AC; McDermott U; Garnett MJ; Cheong SC
Elife; 2020 Sep; 9():. PubMed ID: 32990596
[TBL] [Abstract][Full Text] [Related]
35. The role of non-coding RNAs in drug resistance of oral squamous cell carcinoma and therapeutic potential.
Meng X; Lou QY; Yang WY; Wang YR; Chen R; Wang L; Xu T; Zhang L
Cancer Commun (Lond); 2021 Oct; 41(10):981-1006. PubMed ID: 34289530
[TBL] [Abstract][Full Text] [Related]
36. Re-expression of Lactotransferrin, a candidate tumor suppressor inactivated by promoter hypermethylation, impairs the malignance of oral squamous cell carcinoma cells.
Zhang J; Ling T; Wu H; Wang K
J Oral Pathol Med; 2015 Sep; 44(8):578-84. PubMed ID: 25370482
[TBL] [Abstract][Full Text] [Related]
37. Mitochondrial DNA sequences and transcriptomic profiles for elucidating the genetic underpinnings of cisplatin responsiveness in oral squamous cell carcinoma.
Aminuddin A; Ng PY; Chua EW
BMC Genom Data; 2022 Jun; 23(1):47. PubMed ID: 35729497
[TBL] [Abstract][Full Text] [Related]
38. Targeting the DNA Damage Response in OSCC with TP53 Mutations.
Lindemann A; Takahashi H; Patel AA; Osman AA; Myers JN
J Dent Res; 2018 Jun; 97(6):635-644. PubMed ID: 29489434
[TBL] [Abstract][Full Text] [Related]
39. A YAP/TAZ-Regulated Molecular Signature Is Associated with Oral Squamous Cell Carcinoma.
Hiemer SE; Zhang L; Kartha VK; Packer TS; Almershed M; Noonan V; Kukuruzinska M; Bais MV; Monti S; Varelas X
Mol Cancer Res; 2015 Jun; 13(6):957-68. PubMed ID: 25794680
[TBL] [Abstract][Full Text] [Related]
40. Seven-CpG-based prognostic signature coupled with gene expression predicts survival of oral squamous cell carcinoma.
Shen S; Wang G; Shi Q; Zhang R; Zhao Y; Wei Y; Chen F; Christiani DC
Clin Epigenetics; 2017; 9():88. PubMed ID: 28852427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
